Which current or previous cancers are contraindications to teduglutide (Revestive)?

Teduglutide (Revestive) is contraindicated in patients with any active or suspected malignancy, or a history within the last five years of malignancies in the gastrointestinal tract, including the hepatobiliary system and pancreas.